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High Flow Nasal Cannula (HFNC) is a respiratory modality that has been adopted to support 
pediatric patients with bronchiolitis. There is no standardized protocol for initiation, escalation or 
weaning of HFNC in PICU. The aim of this respiratory therapist (RT)-driven quality 
improvement management protocol is to decrease HFNC duration.
Methods
An RT-driven HFNC management protocol based on an objective respiratory score was 
implemented in 2017 at a quaternary care children’s hospital. Subjects included children less 
than the age of 2 years admitted to the PICU with bronchiolitis. All subjects needing HFNC were 
scored and placed within the protocol as appropriate for age, then weaned or escalated per the 
scoring tool. Comparison to pre-intervention control group was performed. Average HFNC 
duration per subject was used as the primary outcome measure. Protocol compliance was used as 
process measure. Non-invasive ventilation (NIV) use, intubation rate, and 30-day PICU 
readmission rate were used as balancing measures. RT satisfaction with HFNC management pre- 
and post-protocol implementation were measured.
Results
Protocol compliance was sustainable and above the goal of 80% after 4 months of protocol 
implementation. HFNC duration decrease from 2.5 to 2 days/subject during planning and then to 
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1.8 after protocol implementation. PICU length of stay (LOS) and hospital LOS decreased from 
2.6 to 2.1 days and 5.7 to 4.7 days after protocol implementation, respectively. The use of NIV 
and the rate of intubation did not have significant change. RTs reported increased involvement in 
HFNC management decisions and appropriateness on how fast the team weaned HFNC.
Conclusions
A RT-driven HFNC management protocol can be safely implemented in a PICU and decrease 
HFNC duration, PICU LOS, and hospital LOS. It allows the RT to work independently to the 
highest extent of their scope of practice leading to improvement in RT job satisfaction.
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INTRODUCTION
Bronchiolitis is a leading cause of healthcare utilization for infants across the US, with 1 in 5 
children presenting to healthcare providers, and up to 3% of all infants requiring hospitalization1. 
Recent estimates report approximately 150,000 bronchiolitis hospitalizations per year2. National 
hospital charges related to bronchiolitis have been increasing over time, from $1.3 billion in 
2000 to $1.7 billion in 20093.  
High Flow Nasal Cannula (HFNC) is a relatively recent respiratory support modality which 
allows for higher flow rates of oxygen via heating and humidification of the breathing gas when 
compared with standard O2 therapy. HFNC has been utilized for subjects ranging in age from 
preterm neonates to adults and in a variety of disease states. The use of HFNC in bronchiolitis 
has led to a decrease in the need for intubation and hospital length of stay when compared to 
standard O2 therapy4-8. HFNC also decreases reintubation rates within 72 hours after extubation 
when compared with standard O2 therapy9.
Despite the adoption of HFNC as a primary respiratory modality before using non-invasive 
ventilation (NIV) and intubation for bronchiolitis in pediatric intensive care units, there is no 
standardized protocol for initiation, escalation, or weaning of HFNC10. Respiratory therapist 
(RT) driven standardized management protocols have been successfully used in PICUs, 
demonstrating effective and efficient care11-13.  Previous studies show that the implementation of 
inter-professional quality improvement initiatives not only improved patients’ clinical outcomes 
and increased RT satisfaction, but also did not lead to an increase in adverse events14, 15.
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The aim of this quality improvement project was to decrease the duration of HFNC in the PICU 
via a standardized RT-driven HFNC management protocol. 
MATERIALS & METHODS
Setting
This is a quality improvement study that was conducted at Riley Hospital for Children at Indiana 
University Health. Our PICU is a 36-bed multidisciplinary medical-surgical unit with 
approximately 2,500 admissions per year. HFNC by Fisher and Paykel Healthcare (Auckland, 
New Zealand) was used in our hospital and is only available in our intensive care units. Subjects 
are not transferred to the general pediatric ward until they are weaned to standard O2 therapy or 
room air. Traditionally, the HFNC initiation, escalation and weaning decisions have been 
managed by the PICU clinician team (attending, fellow, resident, and advance care providers). 
The study was reviewed and exempted by the Indiana University institutional review board as a 
quality improvement project prior to implementation.
Evaluation Failure Modes of HFNC Management in PICU
A group of pediatric intensivists, a pediatric hospitalist, PICU RTs, and information technology 
specialists met in July 2016 to analyze the failure modes and plan the HFNC management 
protocol (Figure 1).
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RT-Driven HFNC Management Protocol Development, Documentation, and 
Implementation
Between September and October 2016 the team met to establish a protocol, plan education, data 
collection, data analysis and documentation in the electronic medical records (EMR) (Cerner 
Corporation, North Kansas City, Missouri, USA). The protocol utilized the Riley Hospital 
Respiratory Score to objectively assess clinical status of the subjects (Table 1). The score was 
initially created looking at five areas: respiratory rate, retractions, mental status, dyspnea, and 
SpO2 – which came from a review of other scoring systems16-18. The protocol was honed in to 
limit complexity, with the understanding that the protocol would be followed by a multi-
professional group of healthcare team members with varying levels of knowledge, skills, and 
experience19. The scoring tool was incorporated in our EMR before protocol implementation. 
After the protocol was developed, it was added to the HFNC initiation order-set within the EMR, 
which was completed in August of 2017.
Implementation of the protocol occurred in October 2017. The HFNC management protocol is 
shown in detail in Table 2 and Figure 2. Briefly, when any subject was admitted to the PICU 
requiring HFNC, the subject was screened to determine whether they were appropriate for the 
protocol (see study population section below).  If none of the exclusion criteria were met, the 
subject was included unless the physician specifically ordered the discontinuation of the 
protocol. Physician reasons for discontinuation were not protocolized or monitored. The protocol 
was printed, laminated and hung on every HFNC unit in our PICU.
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Protocol Education
Protocol education was completed between August and October of 2017. The education plan 
consisted of a formal presentation and a case study with a written test to demonstrate 
understanding of the protocol and associated EMR documentation. The education was provided 
by the RT supervisor and the clinical specialists in the PICU. Questions and clarifications were 
provided to team members via electronic communication and daily huddles throughout the first 
two months of implementation. Re-education of RTs occurred in May of 2018. Protocol 
compliance audits were done twice weekly and feedback was provided to RTs regarding protocol 
adherence and audit findings monthly through email, face-to-face interactions, and during RT 
meetings and huddles.
Study Measures and Data Collection:
The pre-implementation period was between October 2015 and September 2017 and the post-
implementation period occurred between October 2017 and January 2019. The HFNC duration 
was used as the primary outcome measure, while PICU length of stay (LOS) and hospital LOS 
were used as secondary outcome measures. Protocol compliance was used as a process measure. 
NIV use (which included CPAP and bi-level positive airway pressure), intubation rate, and 30-
days PICU readmission rate were used as balancing measures. For duration of HFNC, data was 
extracted from EMR on a monthly basis to evaluate protocol effectiveness and to provide 
feedback to the team members. Protocol compliance was obtained by weekly auditing of all 
subjects requiring HFNC. Final analysis was conducted on data obtained from Virtual PICU 
Systems (VPS, LLC, Los Angeles, CA, USA). RT satisfaction was conducted pre- and post-
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protocol implementation via electronic surveys using SurveyMonkey (Providence, RI, USA) that 
were sent to all core PICU RTs in June 2017 and January 2019, respectively. 
Subject Population
The HFNC protocol was used in all subjects who required HFNC in the PICU. Exclusion criteria 
at initiation of the protocol were subjects requiring Heliox, nitric oxide, and continuous albuterol 
nebulization. A change was made in the protocol in April of 2019 to include subjects who were 
on continuous albuterol. For this manuscript, we only include subjects who were less than 24 
months of age and had a primary diagnosis of bronchiolitis. Subjects requiring NIV or intubation 
were excluded from analysis of the outcome and process measures and were used only to 
monitor balancing measures.
Statistical Analysis
The QI Macros add-in for Excel Version 2018.09 (KnowWare International, Denver, CO) was 
used to generate the run charts and x-bar statistical process control charts of the outcome and 
process measures. To overcome the seasonal variation impacting the number of subjects with 
bronchiolitis admitted to PICU, subjects were divided into groups of ten. The upper control limit 
(UCL) and lower control limit (LCL) were calculated as three sigma above and below the center 
line (CL). We considered eight consecutive points above or below the CL to represent a special 
cause variation and this prompted a change in the CL20. Subject demographics and clinical 
characteristics in the pre-HFNC and HFNC weaning protocol were compared using appropriate 
parametric and nonparametric tests, Wilcoxon rank-sum test for continuous variables and Chi-
Square tests for categorical variables, with Fisher’s Exact tests being used when cell counts were 
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small. Statistical analysis of the subjects’ characteristics between the two groups was performed 
using Stata Statistical Software Release STATA 12.1 (StatCorp LP, College Station, TX). A 
cutoff p-value of less than 0.05 was considered statistically significant.  
RESULTS
During the HFNC weaning protocol pre-implementation period, there were 257 subjects 
admitted with bronchiolitis compared to 333 subjects in the implementation period 
(Supplemental Table 1). There was no significant difference in subject characteristics between 
pre and during HFNC protocol implementation periods except in female gender (p=0.023) and 
race/ethnicity (p=0.037). 
Protocol compliance started with 50% and gradually improved to a median of 86%, which was 
above our goal of 80% (Figure 3). For the outcome measures, the average HFNC duration per 
subject dropped from 2.5 to 2 days during the planning period for the HFNC management 
protocol. After protocol implementation HFNC duration dropped further to 1.8 days (Figure 4-
A). The average PICU length of stay (LOS) showed a drop from 2.6 to 2.1 days after protocol 
implementation (Figure 4-B). The average hospital LOS also dropped from 5.7 to 4.7 days after 
protocol implementation (Figure 4-C). The use of NIV and rate of intubation did not change after 
protocol implementation; (6.3% vs 3.7%, p=0.13 and 17.3% vs 14.5%, p=0.13), respectively. 
None of the subjects were readmitted to the PICU within 30-days in both the pre implementation 
and HFNC groups.
RTs reported an increase in their involvement in management decisions for subjects on HFNC in 
the PICU (44.5% to 67.9%, p<0.001) (Figure 5-A) and improved perceived appropriateness on 
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how fast the team weaned HFNC (41.7% to 63%. p<0.001) (Figure 5-B). In addition, RTs 
perceived they were less likely to be excluded from HFNC management decisions (62.9% to 
39.3%, p<0.001) (Figure 5-C). 
DISCUSSION
To our knowledge, this is the first reported RT-driven quality improvement HFNC management 
protocol in PICU. A RT-driven protocol can be safely implemented in the PICU and can result in 
decreased HFNC duration, PICU LOS and hospital LOS without increasing PICU readmission, 
NIV or intubation rates. In busy PICUs with high patient acuity, inter-professional collaboration 
between various team members is vital for quality and efficient care for all patients. Protocols 
which allow members of inter-professional team members to work with greater autonomy allow 
for improvement in both patient care and workflow.
We believe that the key components for a successful RT-driven management protocol are based 
on the following components; (1) involving inter-professional team members in analyzing failure 
modes and establishing the protocol, (2) integration of the protocol in EMR which improve the 
communication of protocol adherence between team members, (3) conducting education before 
implementation of the protocol, (4) frequent audits for protocol compliance, providing team 
members with feedback and re-education when needed, and (5) modifying the protocol to reach 
the project’s goals14, 15. 
HFNC is becoming first-line therapy in many PICUs to treat patients with bronchiolitis. 
Standardized clinical pathways have consistently demonstrated cost effectiveness and improved 
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patient outcomes21, 22, yet there are no standards for HFNC management of bronchiolitis 
patients10. The lack of guidelines on how to initiate, escalate, and wean this important modality 
can lead to variation of care, care team and family dissatisfaction, longer occupation of valuable 
PICU beds, and utilization of hospital resources. 
We demonstrated decreases in HFNC duration, PICU LOS, and hospital LOS after 
implementation of HFNC management protocol in our PICU. A decrease in the PICU and 
hospital lengths of stay would decrease overall healthcare costs in an era when healthcare costs 
are increasing23. Our PICU LOS and hospital LOS were shorter than what was reported by 
Betters et. al despite having a younger population in our cohort; 2.1 days and 4.7 days compared 
to 6 days and 10 days, respectively24. The longer LOS in Betters et al could be explained by 
differences in patient population as they included patients with multiple disease processes in 
comparison to a more homogenous population in our study. They also used HFNC as a step-
down respiratory support modality for patients who were intubated or required NIV. We also 
suspect that seasonal variation (which can affect viral severity) may contributed to the 
differences between our two studies.
In a comparison of our protocol to the report published by Betters et. al. regarding implementing 
a HFNC weaning protocol in their PICU24, our management protocol can be more appealing to 
bedside RTs and clinical team members because it is straight-forward and simplified. 
Simplification of the protocol allows RTs with varying experience levels to implement it 
effectively. Our protocol also gives the RT autonomy, not only to wean HFNC, but to also select 
the initial flow and escalate the HFNC until achieving the respiratory score goal. Our protocol 
Page 13 of 35 Respiratory Care
14
was also designed to include physicians of different training levels (residents and fellows) when 
more escalation of care is needed. The protocol also used more frequent assessment to assure 
safety and efficacy in escalation and gradual weaning the HFNC, which may be considered a 
more acceptable approach than doing HFNC holiday as reported by Betters et al. 
It is notable that the duration of HFNC dropped from 2.5 to 2 days during the planning period 
and prior to implementation of the HFNC management protocol. This was a larger decrease than 
that was observed during the implementation period (2 to 1.8 days). This could be in part due to 
informal early adoption of the HFNC protocol by RTs and physician prior to formal 
implementation date given that many of the team members were included in the establishing the 
protocol.
A major strength of our protocol is that it is RT-driven. This allows the RT to have independence 
to the fullest extent of their scope of practice. Despite this protocol adding relative value units to 
the workload of RTs, overall it was looked upon favorably. RTs reported that their job 
satisfaction and involvement improved after protocol implementation. This is important as 
burnout has been linked, across job disciplines, to contribute to worse patient outcomes25. This 
result supports prior studies demonstrating that respiratory care protocol use increases RT 
perceived job satisfaction26.  Our protocol allows RTs to utilize their unique skill sets where best 
suited which can be helpful in busy, high acuity, intensive care units. 
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Limitations
This project utilized an initiative at a single center, making it potentially non-generalizable to 
other centers. The Riley Hospital Respiratory scores have not been validated before 
implementation, also potentially limiting the extrapolation of these findings. Although a recent 
study by Shein et. al. found that the retractions only score correlated with objective measure of 
patient work of breathing, the use of NIV and intubation and was comparable to more complex 
scores19.
It should be noted, that while the protocol compliance improved over time, for 7 of 16 months of 
protocol implementation the compliance rate was below our goal of 80% (Fig. 3). Four of those 7 
months were near the beginning of protocol implementation where the RT and clinical teams 
may need time to get more familiar and comfortable using the protocol. While we implemented 
regular education sessions for RTs, we realize that our protocol compliance reports could have 
been provided in a timelier manner to the RTs on our team.  This could have allowed for more 
consistent compliance rates and might lead to larger reduction in HFNC duration.
It is possible that other extraneous factors may have influenced our PICU and hospital LOS, such 
as ward bed availability, ability for patients to tolerate oral intake, and family circumstances 
which may have prevented the patients from being able to discharge home safely. Several of 
these extraneous factors can be difficult to monitor and were outside of the scope of this study. It 
is also important to consider that provider fatigue may lead to decrease in compliance. We did 
not see this result, but also concluded the continued data analysis in January 2019.
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While we had positive results after implementing our protocol, a multi-center quality 
improvement collaborative project is needed to confirm the benefits of this protocol in other 
centers with different HFNC practices and RT/clinical teams’ staffing models. The safety and 
efficacy of using a modified version of this protocol (with limitation of maximum flow rate of 
HFNC) outside the PICU on a hospitalist service needs further investigation. Such modified 
protocol would free some of the limited PICU beds during months when viral respiratory 
illnesses can overwhelm PICUs
CONCLUSIONS
A Respiratory therapist-driven HFNC management protocol for bronchiolitis can be successfully 
implemented in a pediatric ICU. The protocol can decrease HFNC duration, as well as PICU and 
hospital lengths of stay. Such a protocol improves RT job satisfaction and aids in supporting RTs 
involvement as vital members of the PICU team.
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FIGURE LEGENDS
Figure 1: Key Driver Diagram for HFNC in PICU
EMR: electronic medical records; RN: registered nurse; HFNC: high flow nasal cannula; PICU: 
pediatric intensive care unit; RT: respiratory therapist
Figure 2: Riley Hospital HFNC Management Protocol
HFNC: high flow nasal cannula; MD: physician; NC: nasal cannula; RA: room air; RT: 
respiratory therapist
Figure 3: Run Chart for HFNC Management Protocol Compliance
Figure 3 annotation:
1. Respiratory therapist re-education
Figure 4 A: X-bar Control Chart for Patient’s Average Duration of HFNC
Figure 4 B: X-bar Control Chart for Patient’s Average PICU Length of Stay (LOS)
Figure 4 C: X-bar Control Chart for Patient’s Average Hospital Length of Stay (LOS)
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CL: center line; HFNC: high flow nasal cannula; PICU: pediatric intensive care unit; LCL: lower 
control limit; UCL: upper control limit
Figure 4 annotations:
1. First team meeting to establish the protocol (July 2016)
2. Development of Riley Hospital Respiratory Score (October 2016)
3. Finish electronic medical records protocol integration (August 2017)  
4. Finish respiratory therapist education and protocol implementation (October 2017)
5. Respiratory therapist and Auditor re-education (May 2018)
Figure 5 A: Respiratory Therapists’ Opinion of Their Involvement in HFNC Management 
Decisions in PICU
Figure 5 B: Respiratory Therapists’ Opinion on How Fast the Team Weaned HFNC
Figure 5 C: Respiratory Therapists’ Perception of Barriers to Weaning HFNC Efficiently
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High flow nasal cannula (HFNC) is a respiratory support modality with increasing usage in acute 
respiratory failure in pediatric patients.  HFNC allows for higher flow rates of oxygen via heating 
and humidification of the breathing gas when compared with standard O2 therapy. HFNC has 
been utilized for subjects ranging in age from preterm neonates to adults and in a variety of 
disease states. The use of HFNC in bronchiolitis has led to decrease in the need for intubation 
and hospital length of stay when compared to standard O2 therapy. 
What this paper contributes to our knowledge
A Respiratory therapist-driven HFNC management protocol for bronchiolitis can be successfully 
implemented in a pediatric ICU. Implementation can decrease HFNC duration, as well as PICU 
and hospital lengths of stay.
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Figure 1-HFNC Key Driver Diagram 
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TABLE 1: Riley Hospital Respiratory Score
SCORE 0 1 2
<1 year < 60 61-70 > 70
1-3 years <  40 41-50 > 50
4-5 years <  34 35-42 >42
6-12 years <  30 31-38 >38
Respiratory Rate
≥13 years < 16 17-24 >24
0-1 of the following at least 2 of the following
2 or more of the 
following
Nasal Flaring Nasal Flaring Head Bobbing
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Table 2: HFNC Initial Settings and Escalation Guidelines
Newborn
Up to 1-month 
Yellow Cannula






School-age           
6-12 years
Green Cannula
Adolescent/Adult     
≥ 13 years
Clear Cannula
Initial Settings 6 L/min 8 L/min 10 L/min 12 L/min 15 L/min




Increase flow by 2L 
Q 15-30 minutes to 
14L
Increase flow by 2L 
Q 15-30 minutes to 
20L
Increase flow by 2L 
Q 15-30 minutes to 
20L
Increase flow by 5L 
Q 15-30 minutes to 
40L
Hard Escalation         
Notify PICU 
Attending/Fellow
Increase flow by 2L 
Q 15-30 minutes to a 
maximum of 8L
Above 14L, increase 
flow by 2L Q 15-30 
minutes to a 
maximum of 20L
Above 20L, increase 
flow by 2L Q 15-30 
minutes to a 
maximum of 25L
Above 20L, increase 
flow by 2L Q 15-30 
minutes to a 
maximum of 25L
Above 40L, increase 
flow by 5L Q 15-30 
minutes to a 
maximum of 60L
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Figure 2-HFNC Flowchart 
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Figure 3-Protocol Compliance 
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Figure 4 A-HFNC Duration 
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Figure 4 B-PICU LOS 
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Figure 4 C-Hospital LOS 
119x51mm (1200 x 1200 DPI) 
Page 32 of 35Respiratory Care
For Peer Review
 
Figure 5 A - RT Satisfaction 
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Figure 5 B - RT Satisfaction 
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Figure 5 C - RT Satisfaction 
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